Is this you?
Request access for Cardiology with your @cardiologypc.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall85Recruit63Ops91Sponsor98Ther92
Performance (observed)
Historical trials
800
Completed
446
Terminated/Withdrawn
56
Completion rate
89%
Active now
165
Phase 2
97
Phase 3
131
Realized enrollment
1,010,883
First study year
1992
Years active
35
Match confidence
low (approx)
Enrollment velocity (inf)
28,882
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
751
States
Alabama
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Boston Scientific Corporation; Abbott Medical Devices; Pfizer; Yonsei University; National Institute of Cardiology, Warsaw, Poland; Medtronic Cardiac Rhythm and Heart Failure
CROs
BioCrossroads; Covance; Crouse Hospital; IQVIA Pty Ltd; KCRI; Micro Interventional Devices
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
SDeRamus@cardiologypc.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall85
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.